Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Diabetes

  Free Subscription


Articles published in J Hypertens

Retrieve available abstracts of 33 articles:
HTML format
Text format



Single Articles


    September 2019
  1. HOLTROP J, Spiering W, Nathoe HM, De Borst GJ, et al
    Apparent therapy-resistant hypertension as risk factor for the development of type 2 diabetes mellitus.
    J Hypertens. 2019 Sep 19. doi: 10.1097/HJH.0000000000002227.
    PubMed     Text format     Abstract available


    July 2019
  2. PIPERIDOU A, Sarafidis P, Boutou A, Thomopoulos C, et al
    The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.
    J Hypertens. 2019;37:1334-1343.
    PubMed     Text format     Abstract available


    June 2019
  3. CIFKOVA R, Lanska V, Bruthans J, Mayer O Jr, et al
    Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registr
    J Hypertens. 2019 Jun 24. doi: 10.1097/HJH.0000000000002130.
    PubMed     Text format     Abstract available


    May 2019
  4. THOMOPOULOS C, Bazoukis G, Ilias I, Tsioufis C, et al
    Effects of glucose-lowering on outcome incidence in diabetes mellitus and the modulating role of blood pressure and other clinical variables: overview, meta-analysis of randomized trials.
    J Hypertens. 2019 May 30. doi: 10.1097/HJH.0000000000002152.
    PubMed     Text format     Abstract available


  5. HEAD GA, Shaw JE, Dunstan DW, Owen N, et al
    Hypertension, white-coat hypertension and masked hypertension in Australia: findings from the Australian Diabetes, Obesity, and Lifestyle Study 3.
    J Hypertens. 2019 May 1. doi: 10.1097/HJH.0000000000002087.
    PubMed     Text format     Abstract available


    April 2019
  6. VUKOMANOVIC V, Suzic-Lazic J, Celic V, Cuspidi C, et al
    The relationship between functional capacity and left ventricular strain in patients with uncomplicated type 2 diabetes.
    J Hypertens. 2019 Apr 29. doi: 10.1097/HJH.0000000000002125.
    PubMed     Text format     Abstract available


  7. NAGAI M, Dote K, Kato M, Oda N, et al
    Visit-to-visit blood pressure variability and a risk of diabetic foot ulcers: how calcium channel blockers moderate?
    J Hypertens. 2019;37:860-861.
    PubMed     Text format    


  8. VIAZZI F, Bonino B, Mirijello A, Fioretto P, et al
    Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes.
    J Hypertens. 2019;37:805-813.
    PubMed     Text format     Abstract available


  9. ZHANG Z, Tremblay J, Raelson J, Sofer T, et al
    EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes.
    J Hypertens. 2019;37:775-789.
    PubMed     Text format     Abstract available


    March 2019
  10. LOPEZ-JARAMILLO P, Barbosa E, Molina DI, Sanchez R, et al
    Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome.
    J Hypertens. 2019 Mar 14. doi: 10.1097/HJH.0000000000002072.
    PubMed     Text format     Abstract available


  11. SARMA AV, Hotaling JM, de Boer IH, Dunn RL, et al
    Blood pressure, antihypertensive medication use, and risk of erectile dysfunction in men with type I diabetes.
    J Hypertens. 2019 Mar 14. doi: 10.1097/HJH.0000000000001988.
    PubMed     Text format     Abstract available


    February 2019
  12. DRIESSEN JHM, de Vries F, van Onzenoort HAW, Schram MT, et al
    Metformin use in type 2 diabetic patients is not associated with lower arterial stiffness: the Maastricht Study.
    J Hypertens. 2019;37:365-371.
    PubMed     Text format     Abstract available


    January 2019
  13. YU ZB, Li D, Chen XY, Lin HB, et al
    Prognostic value of visit-to-visit systolic blood pressure variability related to diabetic kidney disease among patients with type 2 diabetes.
    J Hypertens. 2019 Jan 11. doi: 10.1097/HJH.0000000000002038.
    PubMed     Text format     Abstract available


  14. VIAZZI F, Bonino B, Mirijello A, Fioretto P, et al
    Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes.
    J Hypertens. 2019 Jan 7. doi: 10.1097/HJH.0000000000001950.
    PubMed     Text format     Abstract available


    December 2018
  15. COOPER ME, Perkovic V, Groop PH, Hocher B, et al
    Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin-angiotensin system inhibitors in type 2 diabetic patients with albuminuria.
    J Hypertens. 2018 Dec 11. doi: 10.1097/HJH.0000000000002032.
    PubMed     Text format     Abstract available


    November 2018
  16. PALATINI P
    Risk of developing foot ulcers in diabetes: contribution of high visit-to-visit blood pressure variability.
    J Hypertens. 2018;36:2132-2134.
    PubMed     Text format    


    October 2018

  17. Albuminuria and diabetes: a question of eye and skin points of view: Erratum.
    J Hypertens. 2018;36:2121.
    PubMed     Text format    


    August 2018
  18. RAMIREZ AJ, Sanchez MJ, Sanchez RA
    Diabetic patients with essential hypertension treated with amlodipine: blood pressure and arterial stiffness effects of canagliflozin or perindopril.
    J Hypertens. 2018 Aug 14. doi: 10.1097/HJH.0000000000001907.
    PubMed     Text format     Abstract available


    July 2018
  19. LEE CJ, Hwang J, Lee YH, Oh J, et al
    Blood pressure level associated with lowest cardiovascular event in hypertensive diabetic patients.
    J Hypertens. 2018 Jul 13. doi: 10.1097/HJH.0000000000001842.
    PubMed     Text format     Abstract available


  20. VALLEE A, Yannoutsos A, Temmar M, Dreyfuss Tubiana C, et al
    Determinants of the aortic pulse wave velocity index in hypertensive and diabetic patients: predictive and therapeutic implications.
    J Hypertens. 2018 Jul 10. doi: 10.1097/HJH.0000000000001828.
    PubMed     Text format     Abstract available


    May 2018
  21. BRENNAN MB, Guihan M, Budiman-Mak E, Kang H, et al
    Increasing SBP variability is associated with an increased risk of developing incident diabetic foot ulcers.
    J Hypertens. 2018 May 22. doi: 10.1097/HJH.0000000000001783.
    PubMed     Text format     Abstract available


  22. LIU J, Yasuno S, Oba K, Konda M, et al
    Long-term effects of antihypertensive therapy on cardiovascular events and new-onset diabetes mellitus in high-risk hypertensive patients in Japan.
    J Hypertens. 2018 May 9. doi: 10.1097/HJH.0000000000001780.
    PubMed     Text format     Abstract available


  23. VIRDIS A, Masi S, Grassi G
    Albuminuria and diabetes: a question of eye and skin points of view.
    J Hypertens. 2018;36:1036-1037.
    PubMed     Text format    


    April 2018
  24. VIAZZI F, Ceriello A, Fioretto P, Giorda C, et al
    Changes in albuminuria and renal outcome in patients with type 2 diabetes and hypertension: a real-life observational study.
    J Hypertens. 2018 Apr 19. doi: 10.1097/HJH.0000000000001749.
    PubMed     Text format     Abstract available


  25. KOTSIS V, Tsioufis K, Antza C, Seravalle G, et al
    Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease
    J Hypertens. 2018 Apr 12. doi: 10.1097/HJH.0000000000001731.
    PubMed     Text format     Abstract available


  26. KOTSIS V, Jordan J, Micic D, Finer N, et al
    Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hyperten
    J Hypertens. 2018 Apr 9. doi: 10.1097/HJH.0000000000001730.
    PubMed     Text format     Abstract available


    March 2018
  27. BOMBELLI M, Quarti-Trevano F, Tadic M, Facchetti R, et al
    Uric acid and risk of new-onset metabolic syndrome, impaired fasting glucose and diabetes mellitus in a general Italian population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study.
    J Hypertens. 2018 Mar 14. doi: 10.1097/HJH.0000000000001721.
    PubMed     Text format     Abstract available


    January 2018
  28. EGUCHI K, Hoshide S, Kario K
    Target home morning SBP be below 125 mmHg in type 2 diabetes patients.
    J Hypertens. 2018 Jan 23. doi: 10.1097/HJH.0000000000001683.
    PubMed     Text format     Abstract available


  29. YANNOUTSOS A, Bahous SA, Safar ME, Blacher J, et al
    Clinical relevance of aortic stiffness in end-stage renal disease and diabetes: implication for hypertension management.
    J Hypertens. 2018 Jan 2. doi: 10.1097/HJH.0000000000001665.
    PubMed     Text format     Abstract available


  30. ZHANG Y, Jiang X, Bo J, Yin L, et al
    Risk of stroke and coronary heart disease among various levels of blood pressure in diabetic and nondiabetic Chinese patients.
    J Hypertens. 2018;36:93-100.
    PubMed     Text format     Abstract available


  31. AHMAD A, Oparil S
    What is the most appropriate target SBP in persons with hypertension and diabetes mellitus?
    J Hypertens. 2018;36:37-40.
    PubMed     Text format    


    December 2017
  32. USHIGOME E, Matsumoto S, Oyabu C, Kitagawa N, et al
    Prognostic significance of day-by-day variability of home blood pressure on progression to macroalbuminuria in patients with diabetes.
    J Hypertens. 2017 Dec 27. doi: 10.1097/HJH.0000000000001657.
    PubMed     Text format     Abstract available


  33. BEUSCHLEIN F, Reincke M, Arlt W
    The impact of Connshing's syndrome - mild cortisol excess in primary aldosteronism drives diabetes risk.
    J Hypertens. 2017;35:2548.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: